Table 3.

Indicators of glycaemic control and lipid profile between the intervention and control groups at baseline and end line of the 12 weeks intervention

Variables	Intervention (40)		Control (41)		P-valuea
	Mean	sd	Mean	sd
Haemoglobin (g/dl)
Baseline	13⋅3	1⋅8	13⋅8	1⋅6	0⋅173
End line	13⋅5	1⋅8	14⋅2	1⋅7	0⋅048
Difference	0⋅2	1⋅2	0⋅4	1⋅7	0⋅475
HbA1C (%)
Baseline	10⋅5	1⋅2	10⋅1	1⋅2	0⋅154
End line	7⋅4	1⋅2	7⋅8	1⋅2	0⋅211
Difference	−3⋅1	1⋅7	−2⋅3	1⋅0	0⋅009
FBG (mg/dl)
Baseline	204⋅2	1⋅4	187⋅6	1⋅3	0⋅184
End line	131⋅5	1⋅3	138⋅3	1⋅3	0⋅413
Difference	−76⋅5	62⋅9	−50⋅2	43⋅4	0⋅031
Post-prandial Glucose (mg/dl)
Baseline	307⋅3	92⋅6	280⋅5	75⋅7	0⋅163
End line	139⋅6	1⋅4	165⋅0	1⋅5	0⋅042
Difference	−156⋅3	93⋅3	−101⋅9	78⋅0	0⋅006
Total Cholesterol (mg/dl)
Baseline	217⋅9	1⋅2	206⋅2	1⋅2	0⋅239
End line	198⋅1	1⋅2	204⋅7	1⋅2	0⋅448
Difference	−21⋅0	46⋅5	−1⋅9	36⋅1	0⋅042
Triacylglycerol (mg/dl)
Baseline	159⋅7	1⋅7	154⋅7	1⋅5	0⋅768
End line	111⋅3	1⋅6	129⋅2	1⋅5	0⋅124
Difference	−59⋅3	96⋅9	−29⋅3	42⋅9	0⋅074
LDL (mg/dl)
Baseline	144⋅2	39⋅9	133⋅8	39⋅9	0⋅242
End line	128⋅7	1⋅3	131⋅2	1⋅3	0⋅754
Difference	−11⋅0	41⋅7	2⋅4	34⋅6	0⋅119
HDL (mg/dl)
Baseline	42⋅1	1⋅3	43⋅3	1⋅2	0⋅564
End line	43⋅8	1⋅3	45⋅0	1⋅2	0⋅597
Difference	1⋅9	10⋅1	1⋅7	4⋅0	0⋅933
Apoprotein B (mg/dl)
Baseline	121⋅5	1⋅3	114⋅3	1⋅3	0⋅276
End line	117⋅4	1⋅2	120⋅9	1⋅3	0⋅550
Difference	−5⋅7	31⋅5	6⋅6	23⋅8	0⋅051

^aGeometric mean and sd, independent sample T-test significance at P < 0⋅05.